Pig Antibiotic Stewardship: Welfare and Resistance Risk

Reducing antibiotic use in pig production requires welfare-positive alternatives that address disease risk without the resistance consequences of routine prophylactic use.

Key Facts

Pig production accounts for a significant proportion of global veterinary antibiotic use
Prophylactic antibiotic use to prevent disease in healthy animals drives antimicrobial resistance development
Welfare improvements including stocking density reduction, enrichment, and weaning age increase reduce disease incidence
Vaccines are available for many common pig pathogens and reduce the need for antibiotic treatment
Denmark achieved dramatic antibiotic use reduction while maintaining production through management reforms

Welfare Considerations

Antibiotic stewardship and pig welfare are substantially aligned rather than in tension. The disease burden that drives antibiotic use — respiratory infections, enteric disease, skin conditions — reflects welfare problems including overcrowding, early weaning, poor air quality, and inadequate nutrition. Improving welfare conditions reduces disease incidence and therefore antibiotic requirements. This alignment means welfare investment is simultaneously resistance prevention. Farms that demonstrate lowest antibiotic use typically also demonstrate best welfare outcomes across multiple indicators.

What You Can Do

Choose pork from producers with published antibiotic use data demonstrating stewardship
Support voluntary and regulatory antibiotic stewardship programs in pig production
Engage with retailers about requiring antibiotic use transparency from pork suppliers
Advocate for prophylactic antibiotic use bans equivalent to EU regulations in all major producing countries
Support research into disease prevention strategies that reduce antibiotic need while improving welfare